Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Total article views   HTML views PDF downloads Totals
14,917 Dovepress* 13,776+ 1,903 15,679
PubMed Central* 1,141 228 1,369
Totals 14,917 2,131 17,048
*Since 10 January 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar